New articles highlight rift over statins
Tuesday, June 29, 2010 - 12:42
in Health & Medicine
Two studies and a review of previous studies address the widely prescribed cholesterol drugs. One questions their use as a preventive measure; another suggests they help prostate cancer patients. A simmering scientific dispute over statins, the cholesterol-lowering prescription drugs that rake in some $26 billion a year for their makers, heated up Monday with an exchange of published volleys that drove back the...